Latest news
Loading news…
Viewpoint Molecular Targeting develops radiopharmaceutical therapeutics for cancer and complementary diagnostics for personalized medicine.
Viewpoint Molecular Targeting was acquired by IsoRay in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
15
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Coralville, Iowa, United States
- Diversity spotlight
- Women Founded
Key People at Viewpoint Molecular Targeting
Co-Founder and COO
Co-Founder and CEO
Chief Medical Officer
Co-Founder and Chief Science Officer
15
professional contacts at Viewpoint Molecular Targeting
Contact execs at Viewpoint Molecular Targeting →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Viewpoint Molecular Targeting
Loading news…
FAQs about Viewpoint Molecular Targeting
People who checked this page also checked these
Browse the full Acquirezy directory.